Stem Cell Sciences Inc is categorized under Organ and Tissue Banks in New York City, NY and active since 1992.
Stem Cell Sciences Inc was established in 1992, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Organ and Tissue Banks business, which does work in the B2C market, and is classified as a Organ and Tissue Banks, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Nicholas Ciiobanu at the company’s single location by writing to 10 East 38th St, New York City, New York NY 10016 or by phoning (212) 481-0900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Stem Cell Sciences Inc |
| Contact Person: | Nicholas Ciiobanu |
| Address: | 10 East 38th St, New York City, New York 10016 |
| Phone Number: | (212) 481-0900 |
| Website Address: | stem-cell.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1992 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Organ and Tissue Banks |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Stem Cell Sciences Inc was started in 1992 to provide professional Organ and Tissue Banks under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Nicholas Ciiobanu for inquiries that concern Stem Cell Sciences Inc by calling the company number (212) 481-0900, as your correspondence is most welcome. Additionally, the physical location of the single location of Stem Cell Sciences Inc can be found at the coordinates 40.75055,-73.98181 as well as the street address 10 East 38th St in New York City, New York 10016.
For its online presence, you may visit Stem Cell Sciences Inc’s website at stem-cell.com and engage with its social media outlets through on Twitter and on Facebook.